Results 71 to 80 of about 23,251 (236)
Approach to Nail Pitting in Pediatric and Adolescent Patients: A Dermatology Perspective
JEADV Clinical Practice, EarlyView.ABSTRACT This narrative review aims to discuss the etiologies of nail pitting in pediatric and adolescent patients, while providing a framework for further evaluation of possible underlying systemic conditions and their clinical findings from a dermatologic standpoint.
Elizabeth Botto +3 more
wiley +1 more source
CORTICOSTEROID AS TREATMENT OF ALOPECIA AREATA
e-Jurnal Medika Udayana, 2013 Alopecia areata is a common cause of alopecia nonscarring. Incidence alopecia areata 1-2% of the population, with the same ratio in both sexes, and occurs in all racial groups.
Ni Putu Junika Putri, I Wayan Sugiritama
doaj
Study on Serum Vitamin D in Alopecia Areata Patients
Journal of Nepal Health Research Council, 2019 Background: Alopecia areata is the commonest cause of non-scarring alopecia. Few previous studies have found correlation between AA and vitamin D deficiency, suggesting that vitamin D deficiency can be a risk factor for Alopecia areata. To compare serum
Suchana Marahatta +2 more
doaj +1 more source
Alopecia Areata Associated with Localized Vitiligo
Case Reports in Dermatology, 2010 Alopecia areata is a common cause of noncicatricial alopecia that occurs in a patchy, confluent or diffuse pattern. It may occur as a single, self-limiting episode or may recur at varying intervals over many years. The association of alopecia areata with
Shankarling D. Kuchabal, D.S. Kuchabal
doaj +1 more source
Efficacy and safety of methotrexate in alopecia areata [PDF]
Anais Brasileiros de Dermatologia, 2014 BACKGROUND: Alopecia areata is a chronic disorder of the hair follicles and nails, of unknown etiology, with clear autoimmune components and genetic factors.
Mariana Hammerschmidt +1 more
doaj +1 more source
Treatment of lipomas and diffuse lipomatosis with NDYAG 1064 NM laser and their impact on the quality of life [PDF]
, 2020 Lipomas, the most common type of benign tumours, are generally developed from adipose tissue and present an incidence of 2.1 per 1000 inhabitants. In addition to lipomas, at least three other maladies of the adipose tissue lead patients to consult a ...
Andronache, Liliana Florina +5 more
core +3 more sources
The Journal of Dermatology, EarlyView.ABSTRACT Baricitinib and ritlecitinib are newly approved systemic Janus kinase (JAK) inhibitors for severe, refractory alopecia areata (AA). Although clinical trials have demonstrated their efficacy, real‐world evidence remains limited, particularly regarding predictors of response and outcomes following treatment interruption or dose tapering.
Rina Hayashi +2 more
wiley +1 more source
Trichoscopy criteria for diagnosing female androgenic alopecia. [PDF]
, 2008 Differential diagnosis of chronic hair loss remains a challenge in dermatology. The aim of the study was to evaluate the value of a new scalp visualization technique, trichoscopy, in differential diagnosis of hair loss.
Adriana Rakowska +4 more
core +1 more source
Risk of Safety Events in Vitiligo Patients: A Retrospective Real‐World Data Study in the US
The Journal of Dermatology, EarlyView.ABSTRACT Vitiligo is a chronic autoimmune depigmenting disease characterized by loss of pigment in the skin, hair, or both. As treatment options evolve, particularly with the emergence of oral Janus kinase inhibitors and dual Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor, it is essential to assess ...
Kennedy Cook +11 more
wiley +1 more source
Chemotherapy-induced alopecia: A novel observation [PDF]
, 2018 no abstract ...
Carlesimo, Marta +5 more
core +1 more source